ASIC approves C3 name change

By Dylan Bushell-Embling
Tuesday, 17 June, 2008

The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.

The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Elevated blood protein levels predict mortality

Proteins that play key roles in the development of diseases such as cancer and inflammation may...

Content from other channels on our network

Four food safety tips for the silly season

Santa creates a spike in Australia's milk demand

Spicing up the festive season with Australian bushfood flavours

Kraft Heinz appoints Steve Cahillane as CEO

Irish drinks manufacturer takes its supply chain to the next level

Could this tailored heart pump transform care for half of heart failure patients?

Monash University tailored heart pump — laboratory set-up

Minderoo Children's Comprehensive Cancer Centre, Randwick

Hospital fined $230K after aged care chair detachment

Helping to keep health care professionals hands-on

Sustainability in 2026: what's next for Australian businesses?

How Australia can increase its circularity rate

$25m grant supports cleaner cement production

Bürkert team to take on sustainability strategies

ASC certifies NT barramundi farm